Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00720304 · OUTCOME

Predictive Values of EGFR/TGF-α, VEGF

Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck · Source last updated 2024-08-22

This outcome was registered, but no numerical results were posted in the captured record.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
collection at baseline and periodically during study.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denom Units Selected
Participants
reporting Status
NOT_POSTED
time Frame
collection at baseline and periodically during study.
title
Predictive Values of EGFR/TGF-α, VEGF
type
OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice